Week 210 Review - Just keep piling on the misery

It's taken till Sunday evening for me to be bothered writing anything this week, as sheer misery has taken hold. The combined portfolios were already hammered, but took a £4,967 beating this week to increase the deficit to a whopping £25,161 and drop the portfolio value to £79,383. My best companies are all ridiculously cheap, but I spent all my ammunition a few weeks ago when I had the pension transfer money and the proceeds from selling CEY:Centamin. I acted too early and now all I can do is watch and hope. It's so frustrating that people can rock up and buy companies I've been invested in for years at a lower price than I have paid, possibly just before they start to make real profits. I'm terribly, terribly vexed!

The worst performer was CAML:Central Asia Metals hit by Brexit fears and low metal prices and dropping 8% to go 10% down overall. It shouldn't be, as they showed last time the metal prices were low that they still make lots of profit and the dividend will yield about 10% at this share price. Not only that, they have enough cash to potentially take advantage of these prices to buy out another low cost producer cheap. I'd be filling my boots if I had any spare cash.

SBTX:SkinBioTherapeutics also fell 8% on no news when a deal was expected to be imminent. They are now 22% down and my attempts to trade them have failed miserably.

OPTI:Optibiotix had another dreadful week on hardly any volume despite more good news. There's always good news, and yet the price keeps dropping. I think there's an assumption H1 revenues won't be as high as the market hoped, and people are bailing out anticipating a drop to even lower levels. Many have been stopped out of spread bets too, so fueling the dip. The interesting thing is £500K worth of SBTX shares were sold last week to an institutional investor to raise cash for something - but what? Let's hope it's juicy and lets hope it's this week.

Quite hard to pick Share of the week as the highest risers were only 3%. I'll give it to BLU:Blue Star Capital because it looks like something is going on and there were some massive purchases last week so a flutter of excitement. TRMR:Tremor also climbed 3% but they are ultra volatile so I'm not reading anything into it.

I'm nearer the injection line than the cost line. That's not good.

What a year!

The ISA and share portfolios look like this

			Weekly Change
Cash	£23.52		+£0
Portfolio cost	£57,992.82		+£0
Portfolio sell value (bid price-commission)	£42,478.79	(-26.7%)	-£2,447.83
Potential profits	£0		+£0
Yr 5 Dividends	£0		+£0
Yr 5 Profit from sales	£0		+£0
Yr 5 Average monthly cash profit	£0	(0%)	+£0
Total Dividends	£1,342.30		+£0
Total Profit from sales	£20,391.41		+£0
Average monthly cash profit	£444.52	(9.2%)	-£2.13
(Sold stocks profit + Dividends - Fees  / Months)

Not much to say. Really, really bad.

Dangerously close to the injection line where I would have been better off putting it under the mattress.

Worst ever losses.

The SIPP looks like this after week 194

			Weekly Change
Cash	£15.52		+£0
Portfolio cost	£44,226.49		+£0
Portfolio sell value (bid price - commission)	£35,583.69	(-19.5%)	-£2,448.94
Potential profits	£0		+£0
Yr 4 Dividends	£361.99		+£0
Yr 4 Interest	£0.09		+£0
Yr 4 Profit from sales	£1,440.43		+£0
Yr 4 Average monthly cash profit	£191.62	(5.2%)	-£5.18
Total Dividends	£1,704.24		+£0
Total Interest	£0.12		+£0
Total Profit from sales	£11,985.35		+£0
Average monthly cash profit	£296.76	(8.1%)	-£1.53
(Sold stocks profit + Dividends - Fees / Months)

Exactly the same situation as the ISA. Hit a bit harder because of having both OPTI:Optibiotix and CAML:Central Asia Metals.

A better gap to injection value on this one

This is a much steeper drop though.

The trading account looks like this after week 160

			Weekly Change
Cash	£35.04		+£0
Portfolio cost	£2,321.29		+£0
Portfolio sell value (bid price - commission)	£1,247.07	(-46.3%)	-£31.09
Potential profits	£0		+£0
Year 4 Dividends	£0		+£0
Year 4 Profit	£0		+£0
Yr 4 Average monthly cash profit	£0	(0%)	+£0
Dividends	£34.72		+£0
Profit from sales	-£64.29		+£0
Average monthly cash profit	-£0.80	(-0.4%)	+£0.01
(Sold stocks profit + Dividends - Fees  / Months)

Considering the damage elsewhere, this drop isn't so bad.

A couple of months ago it looked like we were climbing slowly. Not any more.

It's on the trend line - I need a new trend!

Here's the dismal fantasy stock performance

I've only dropped 68 places in the league from 492nd to 560th.

Buying LGEN:Legal & General last week was a really great move. My timing always sucks. Should have just bought gold mines.

I have dim hopes of ever having another good week. I know it will come at some point, and the rebound could be spectacular. At the moment it looks like a distant dream.